HCP's views are changing
A key takeout from the survey is that a whopping 57% of US HCPs have changed their perception of a medication as a result of information seen on social media. This then leads to changes in prescribing habits for 41% of them. 46% of HCP's surveyed follow fellow HCPs and HCP influencers on social media. Interestingly, only 16% of surveyed HCPs reported that their perceptions have never been influenced by social media.
Platform Preferences
As to how they are using the platforms available:
A key takeout from the survey is that a whopping 57% of US HCPs have changed their perception of a medication as a result of information seen on social media. This then leads to changes in prescribing habits for 41% of them. 46% of HCP's surveyed follow fellow HCPs and HCP influencers on social media. Interestingly, only 16% of surveyed HCPs reported that their perceptions have never been influenced by social media.
Pharma marketers are investing in social media
US pharma marketers are quick to recognise the value of social media as a key component in their marketing strategy, with 94% of pharmaceutical marketers seeing social media as vital for HCPs.
US pharma marketers are quick to recognise the value of social media as a key component in their marketing strategy, with 94% of pharmaceutical marketers seeing social media as vital for HCPs.
- 90% have included social media in their 2023 marketing plans, with 50% planning to increase their social media budgets for HCPs.
- 92% of marketers believe social media influences clinical decisions.
-
56% are planning digital influencer programs for 2023.
Platform Preferences
As to how they are using the platforms available:
- Physician communities like Doximity and Sermo are top choices for clinical purposes.
- Facebook is popular for private medical groups.
- LinkedIn is helpful for updates on presentations.
- X (formerly Twitter) is used to follow hospitals and organisations.